A total of 10 metallo-␤-lactamase-producing isolates of six different species, including Brevundimonas diminuta (n ‫؍‬ 3), Rhizobium radiobacter (n ‫؍‬ 2), Pseudomonas monteilii (n ‫؍‬ 1), Pseudomonas aeruginosa (n ‫؍‬ 2), Ochrobactrum anthropi (n ‫؍‬ 1), and Enterobacter ludwigii (n ‫؍‬ 1), were detected in the sewage water of a hospital. The presence of bla VIM-13 associated with a Tn1721-class 1 integron structure was detected in all but one of the isolates (E. ludwigii, which produced VIM-2), and in two of them (R. radiobacter), this structure was located on a plasmid, suggesting that environmental bacteria represent a reservoir for the dissemination of clinically relevant metallo-␤-lactamase genes.
Metallo-␤-lactamases (MBLs) have emerged worldwide as a major source of acquired broad-spectrum ␤-lactam resistance. They hydrolyze virtually all classes of ␤-lactams (except monobactams), including carbapenems, which often represent the last option for the treatment of infections with multidrugresistant Gram-negative bacteria.
There are two dominant types of transferable MBLs among clinical isolates, IMP and VIM (12) . Most of the IMP-and VIM-type MBL genes are present as gene cassettes inserted into integrons located on the chromosome or on plasmids. These integrons may be associated with transposon-like structures which may contribute to their variable location and spread (12) . Interestingly, these MBL genes have been found almost exclusively in the hospital setting and the role of nonclinical habitats as a reservoir for bacteria that carry these acquired resistance determinants has been poorly investigated (9, 10) .
In this study, we evaluated the presence of MBL-producing bacteria in the sewage water of Son Llatzer Hospital (Mallorca, Spain) in order to obtain epidemiological data which could complement the results from a previous survey that investigated the incidence of MBL-producing Pseudomonas aeruginosa strains in this hospital (4) .
For this purpose, duplicates of up to six 10-fold dilutions of 1 liter of sewage water collected 20 m downstream of the hospital wastewater discharge site were plated on three different media specially designed for the selection of pseudomonads (Gould S1 agar [1] , King B agar [6] , and cetrimide agar [Merck, Darmstadt, Germany]) containing 30 g/ml ceftazidime (Combinopharm, Madrid, Spain). A total of 37 bacterial isolates corresponding to different colony morphologies were collected using this strategy and tested for the presence of MBL using the MBL Etest according to the manufacturer's instructions (bioMérieux, Marcy l'Etoile, France). Only 16 isolates were positive by this test.
Although these 16 MBL Etest-positive isolates exhibited different colony morphologies, their identification by 16S rRNA gene amplification and sequencing as previously described (13) showed that they belonged to only eight different species, including Brevundimonas diminuta, Rhizobium radiobacter, Pseudomonas monteilii, P. aeruginosa, Ochrobactrum anthropi, Enterobacter ludwigii, Acinetobacter johnsonii, and Stenotrophomonas maltophilia (Table 1) . Isolates belonging to the same species were not genetically related, as we demonstrated by enterobacterial repetitive intergenic consensus sequencing-PCR (11; data not shown). Furthermore, pulsed-field gel electrophoresis (PFGE) typing (2) revealed that the two P. aeruginosa isolates were different and not related to the MBLproducing P. aeruginosa clinical isolate (PA-SL2) collected in a previous survey (4; data not shown). Given that S. maltophilia produces an intrinsic MBL, we did not further investigate those isolates.
In order to verify the presence of MBLs in the MBL Etestpositive isolates, we determined their ability to hydrolyze imipenem and whether this hydrolysis was EDTA sensitive (7) . The capacity to hydrolyze imipenem that was exhibited by all of the isolates was inhibited by EDTA in all cases, except for the A. johnsonii isolates, which showed only a weak hydrolysis that was not inhibited (Table 1) . Moreover, the A. johnsonii isolates were found to produce the class D carbapenemase OXA-58 by PCR and sequencing, suggesting a false-positive MBL Etest result. In contrast, PCR amplification using primers specific for bla VIM-1, bla VIM-2 , and bla VIM-13 and conditions previously de-scribed (2, 4) revealed the presence of VIM-type MBLs in all of the other isolates (Table 1) . Interestingly, sequence analysis of the resulting amplicons revealed the presence of bla VIM-13 (4) in all of the isolates except E. ludwigii, which presented bla VIM-2 (Table 1) . Moreover, the P. monteilii isolate was positive for both bla VIM-13 and bla VIM-2 .
Given that bla VIM-13 was predominant among the isolates collected, we focused on the characterization of the microorganisms harboring this MBL gene. The susceptibility of the bla VIM-13 -harboring isolates and reference strains to a number of antibiotics was determined by Etest (bioMérieux) following the manufacturer's instructions ( Table 2 ). All of the bla VIM-13 -harboring isolates had similar patterns of multiresistance, showing, in addition to the MBL-mediated resistance to penicillins, cephalosporins, and carbapenems, resistance to gentamicin, tobramycin, and amikacin, with the exception of the P. monteilii isolate, which was susceptible to aminoglycosides. Furthermore, most of them showed increased resistance to ciprofloxacin and trimethoprim-sulfamethoxazole, compared to that of the reference strain. All of the isolates were uniformly susceptible to colistin and minocycline, except B. diminuta and O. anthropi, which were resistant to colistin, and P. aeruginosa, which was resistant to minocycline.
PCR amplification and sequencing, using the primers and 
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on September 7, 2017 by guest http://aac.asm.org/ conditions previously described (4), showed that the integron harboring bla VIM-13 was the same in all of the isolates and identical to the integron previously described in P. aeruginosa clinical isolate PA-SL2 (GenBank accession number EF577407.1) (4) (Fig. 1) . According to previously published data (4), bla in PA-SL2 is located in a class 1 integron, where it is flanked on the left by intI1 and on the right by aacA4 and qacE⌬1. Furthermore, compared to bla VIM-1 , bla VIM-13 shows a higher efficiency of hydrolysis of carbapenems but a lower efficiency of hydrolysis of ceftazidime and cefepime, due to two substitutions (Leu224His, Arg228Ser) within the activesite center (4). Extended cloning and sequencing experiments in this work revealed that, in P. aeruginosa PA-SL2, the integron harboring bla VIM-13 was flanked on the left by the resolvase-and transposase-encoding genes (tnpR and tnpA, respectively) of the Tn1721 transposon (GenBank accession number EU195449) (Fig. 1) , suggesting that the integron could be mobilized by the Tn1721 machinery. Moreover, the integron contained four open reading frames, including tniB (GenBank accession number AJ863570) (Fig.  1) , which could represent a remnant of the original tni locus of the Tn402-In16 integron.
To investigate whether the genes flanking the integron harboring bla VIM-13 in PA-SL2 were also present in the environmental isolates, we performed a series of PCR amplifications using the set of primers represented in Fig. 1 . As shown in Fig.  1 , all of the B. diminuta isolates, one R. radiobacter isolate, and one P. aeruginosa isolate showed positive PCR results with all of the pairs of primers. Furthermore, all of the PCRs yielded products of the same size as those obtained with DNA from P. aeruginosa clinical strain PA-SL2. The other P. aeruginosa isolate and isolates of R. radiobacter and P. monteilii yielded PCR products with sizes identical to that of PA-SL2 on the right flank of the integron, while on the left flank they showed different results that ranged from positive reactions with PCR products larger than the expected sizes to absence of amplification. Finally, genomic DNA amplification of the O. anthropi isolate was positive with only one pair of primers located on the left side of the integron, which yielded a product 700 bp larger than that obtained with PA-SL2. The presence of a bla VIM -like gene in a transposon-integron structure in both clinical and environmental microorganisms has been reported for other MBL genes, such as bla VIM-2 (5), suggesting that the MBL integrons could be mobilized using the transposon machinery.
To investigate whether the wide spread of bla VIM-13 among different environmental microorganisms was due to the location of this gene on a plasmid, genomic DNA of each of the environmental isolates harboring bla VIM-13 was digested with I-Ceu1, separated by PFGE, and hybridized with bla VIM-13 and rRNA probes as described previously (3) . In the R. radiobacter isolates, the bla VIM-13 probe hybridized with bands which did not hybridize with the rRNA genes, suggesting that in these isolates, the bla VIM-13 gene is located in a plasmid, whereas matching of bla and rRNA probes in all of the other isolates indicated a chromosomal location (data not shown). on September 7, 2017 by guest http://aac.asm.org/ Altogether, our results suggest that environmental microbiota may represent an important reservoir of genetic determinants of antimicrobial resistance such as a class 1 integron harboring bla and that the "sewage habitat" can be considered a gathering place where many different species, including potential pathogens like P. aeruginosa, exist and those genetic determinants might be transferred among them.
